Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
AMLXAmylyx(AMLX) Zacks Investment Research·2024-05-09 21:16

Amylyx Pharmaceuticals, Inc. (AMLX) came out with a quarterly loss of 0.46pershareversustheZacksConsensusEstimateof0.46 per share versus the Zacks Consensus Estimate of 0.24. This compares to earnings of 0.02pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−291.670.02 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -291.67%. A quarter ago, it was expected that this company would post earnings of 0.20 per share when it actually produced earnings of $0.07, delivering a surprise of -65%. Over the last four quarters, the company ...